Clay Siegall Posts and Runs Things at Seattle Genetics Company

Clay Siegall was among the founders of Seattle Genetics company. It was with a vision to publish research that Seattle genetics was founded in 1998. Clay Siegall is the chair of the company’s board of directors. He is also Seattle Genetics chief executive. As CEO, Clay has so far been able to secure a cumulative $1.2 billion to facilitate research. The money has come entirely from the private sector.

About Seattle Genetics

Clay has led Seattle Genetics into developing antibody medication. Owing to its determination in research, Seattle genetics was given the green light by FDA to develop a certain drug: ADCENTRIS. This product is now used around the globe in 60 countries. Clay Siegall saw the benefits of partnering with Takeda Pharmaceuticals to boost the accessibility of the drug. The partnership is already making a difference now that over 60 countries can access the medication.


Clay Siegal is not a stranger to celebrity and accolades. His old University, ‘University of Maryland’ leads the way in recognizing the work of Siegall. He received the ‘Alumnus of the Year’ award from the university in 2013 for his contribution to science. Clay is also the recipient of the ‘Ernest & Young Entrepreneurship of the Year Award’. Clay is a seasoned writer who has fifteen patents and many journal contributions.


Clay studied zoology as an undergraduate at the ‘University of Maryland’. After his masters, he still went back to university where he earned his Ph.D at ‘George Washington University’. He studied genetics.

Blog Pots

Clay loves to read and research. His posts are scientific and also social. In a recent post he highlights what scientists believe to be the negative consequences of solitary cells in prison. Solitary confinement is meant to discipline inmates who are unruly and even riotous. This confinement is discouraged by scientists who point out the psychological suffering that the inmate faces once subjected to this punishment.

In yet another post, Siegall displays the argument that combatants in the field who use heavy firing equipment risk damaging their brain. Scientists are researching this hypothesis to determine whether it is true or otherwise.